Cite
Lacticaseibacillus casei CNRZ1874 supplementation promotes M1 alveolar macrophage activation and attenuates Mycoplasma pneumoniae pneumonia.
MLA
Zhang, Naiyu, et al. “Lacticaseibacillus Casei CNRZ1874 Supplementation Promotes M1 Alveolar Macrophage Activation and Attenuates Mycoplasma Pneumoniae Pneumonia.” Journal of Applied Microbiology, vol. 134, no. 3, Mar. 2023, pp. 1–9. EBSCOhost, https://doi.org/10.1093/jambio/lxad022.
APA
Zhang, N., Zeng, W., Du, T., Wei, H., Tian, W., Meng, Y., He, G., Lei, A., & Zhu, C. (2023). Lacticaseibacillus casei CNRZ1874 supplementation promotes M1 alveolar macrophage activation and attenuates Mycoplasma pneumoniae pneumonia. Journal of Applied Microbiology, 134(3), 1–9. https://doi.org/10.1093/jambio/lxad022
Chicago
Zhang, Naiyu, Wuwei Zeng, Tingfeng Du, Hongjiang Wei, Wei Tian, Yan Meng, Guiting He, Aihua Lei, and Cuiming Zhu. 2023. “Lacticaseibacillus Casei CNRZ1874 Supplementation Promotes M1 Alveolar Macrophage Activation and Attenuates Mycoplasma Pneumoniae Pneumonia.” Journal of Applied Microbiology 134 (3): 1–9. doi:10.1093/jambio/lxad022.